Abstract Recent decades have brought marked advances in cardiac imaging. Although the single imaging techniques have seen their fields of application expanding, the definition of cardiac pathophysiology frequently demands a multimodality approach. In fact, multimodality imaging offers the chance to perform an integrated anatomo-functional cardiac evaluation in a completely non-invasive manner. This result is obtained by combining the information derived from mainly anatomical imaging modalities, such as multi-slice computed tomography and magnetic resonance, with the functional measures derived from nuclear imaging techniques, single photon emission computed tomography or positron emission tomography. This review will focus on the clinical applications of multimodality cardiac imaging, explaining the need for an integrated evaluation of myocardial structure and function that may enhance the clinician's ability to characterize cardiac pathology.
Introduction
In the cardiovascular field, the advances in imaging technologies have been dramatic, and cardiac imaging now represents one of the leading causes of the rise in cardiac medical expenditure [1, 2] .
Notably, the different non-invasive cardiac imaging modalities, single photon emission computed tomography (SPECT), positron emission tomography (PET), multi-slice computed tomography (MSCT), and magnetic resonance (MR), have seen a steady increase in their fields of application together with a considerable enhancement of their diagnostic capabilities.
While giving capital information on regional myocardial blood flow regulation, a standard SPECT myocardial perfusion imaging (MPI) study may also shed light on myocardial function as well as cardiac regional contractility and synchronicity [3, 4] . Likewise, a modern cardiac MSCT evaluation allows physicians to integrate robust evaluation of coronary artery anatomy [5] with non-invasive assessment of myocardial perfusion and contractile function [3, 5] .
Nevertheless, even though the abilities of the different techniques have been refined, increasing the types of information that clinicians may acquire from a single study, a multimodality approach is often needed to obtain a comprehensive anatomo-functional cardiac evaluation.
In this context, due to their complementary nature and wide diffusion, nuclear techniques and MSCT have been classically considered ideal partners and constitute the backbone of a modern multimodality cardiac imaging approach [6] . While MSCT can assess the presence of coronary stenoses, nuclear imaging can evaluate their functional consequences, reducing referrals for invasive coronary angiography (ICA) and/or interventions [7] (Figs. 1, 2 ).
According to this concept, the imaging datasets from the two different modalities performed on separate SPECT or PET devices and MSCT scanners may be co-registered and fused by means of dedicated software programs (i.e., software co-registration).
Alternatively, dedicated hybrid scanners that combine either a SPECT or PET device with ''state-of-the-art'' MSCT may be used (i.e., hardware co-registration), simplifying image fusion while improving patient tolerance. This review will focus on the clinical applications of multimodality imaging, outlining the major advantages and drawbacks of the single imaging modalities and the reasons for performing an integrated anatomo-functional cardiac evaluation.
Nuclear imaging and coronary CT: two sides of the same coin Nuclear imaging techniques are widespread and they are by far the most validated methods for the evaluation of myocardial perfusion [8] . Among the nuclear imaging modalities, cardiac PET has been shown to be more accurate than standard SPECT imaging for the assessment of myocardial perfusion abnormalities [9] , providing a unique opportunity to obtain absolute quantification of regional myocardial blood flow [10] . In this regard, a recent meta-analysis showed that PET MPI has high sensitivity (92.6 %) and specificity (81.3 %) in identifying significant coronary stenoses [9] (Fig. 3) . The reasons for this better accuracy include higher spatial and contrast resolution and depth-independent attenuation correction. In fact, cardiac PET may be able to show subtle alterations of myocardial perfusion and may represent the most costeffective imaging test for the evaluation of myocardial ischemia in patients with intermediate probability of coronary artery disease (CAD) [11] .
On the other hand, cardiac SPECT is extremely common and still represents the backbone of nuclear cardiology, serving as a reference technique for the non-invasive evaluation of myocardial perfusion. As classically reported, the overall sensitivity and specificity of cardiac SPECT for the detection of significant CAD ([50 % stenosis) approaches 91 and 87 %, respectively [12] . However, while cardiac SPECT MPI represents a cost-effective gatekeeper to ICA in patients with CAD [8] , it has several specific drawbacks that should be taken into account. Offering a qualitative evaluation of myocardial perfusion, cardiac SPECT MPI may only unmask coronary territories supplied by the most severe stenosis. Moreover, as shown by Berman et al. [13] a considerable proportion of high-risk patients with significant left main disease may present near-normal MPI scans, possibly as a result of ''balanced myocardial ischemia''.
The introduction of newer dedicated multi-pinhole solid-state cardiac cameras with cadmium-zinc-telluride (CZT) detectors might overcome these limitations and open up the possibility of obtaining better evaluation of regional myocardial perfusion [14] . As a matter of fact, CZT imaging has been reported to give a lower rate of equivocal results than standard SPECT in the evaluation of myocardial ischemia despite a faster acquisition protocol and considerably lower radiation dose [15] .
On the other hand, while nuclear techniques are the reference methods for the evaluation of myocardial perfusion, MSCT is the most widespread and validated method for the non-invasive assessment of coronary anatomy. In patients with a low-to-intermediate prevalence of CAD, 64-multidetector row MSCT angiography showed a sensitivity and specificity to detect [50 % or [70 % stenosis of 95 and 83 %, respectively, and 94 and 83 %, respectively [16] .
However, MSCT coronary angiography cannot assess the functional relevance of a given coronary stenosis. Indeed, patients with CAD can show unexpected variability of myocardial perfusion, and nearly half of patients with angiographically significant coronary narrowings on MSCT angiography may not have evidence of inducible ischemia in the pertinent vessel territories [17] . Similarly, a sizeable portion of patients with only non-significant coronary stenosis on MSCT may still present inducible ischemia on SPECT [17] . Integrated assessment of coronary anatomy and myocardial perfusion is therefore warranted to reduce inappropriate invasive procedures and improper coronary revascularizations.
Image fusion and hybrid imaging
Recent studies have suggested that the presence and extent of myocardial ischemia, rather than the angiographic severity of coronary atherosclerosis, might be the major predictor of adverse prognosis in patients with stable CAD [18] . This evidence highlights the importance of an integrated evaluation of coronary anatomy and myocardial perfusion in patients with stable CAD to assess the need for an invasive approach.
Hybrid imaging offers the chance to perform such an evaluation in a completely non-invasive manner, because it combines the high diagnostic accuracy of MSCT coronary angiography with the functional information provided by nuclear imaging in the assessment of regional myocardial perfusion and myocardial viability [8] (Table 1) .
To accomplish this objective, two different approaches to obtain image co-registration may be used, i.e., softwareor hardware-based co-registration.
Hardware-based image co-registration relies on the use of hybrid SPECT/CT or PET/CT scanners capable of performing scintigraphic and CT acquisitions with the patient in a fixed position, allowing better image co-registration. However, due to specific characteristics of cardiac imaging, such as beat-to-beat variation of heart position and respiratory motion, a manual image co-registration is often necessary [19] .
Alternatively, image datasets may be obtained separately using two distinct scanners and subsequently fused by means of commercially available cardiac fusion software using landmark-based techniques [20] . This approach would exploit the advantage of performing state-of-the-art imaging acquisition with separate MSCT and SPECT scanners, while facilitating imaging workflow.
In this respect, the recent introduction of hybrid scanners equipped with novel dedicated CZT cardiac cameras, characterized by a significantly lower acquisition time than standard cameras, might overcome the unfavorable discrepancy in scan duration between MSCT and nuclear imaging acquisition [14, 15] .
Another novel field of interest is that of the integration of PET or SPECT devices with high-end MR scanners, offering superior, radiation-free, soft-tissue characterization [21] .
Multimodality cardiac imaging: indications and clinical application
The clinical relevance of hybrid imaging, i.e., the integration of nuclear perfusion techniques and MSCT, has been already documented [22] . In this regard, Gaemperli et al. [20] showed that in almost one-third of the patients submitted to SPECT MPI and MSCT evaluation, the analysis of SPECT/ MSCT fusion images provided added diagnostic information on lesion functional severity over the standard side-by-side analysis. The relative inaccuracy of side-by-side analysis of nuclear imaging data and coronary anatomy may also be related to the high inter-subject morphological variability of the coronary tree. In fact, standard assumptions on vascular territory distribution in MPI are inaccurate in the majority of patients, leading to erroneous allocation of myocardial ischemia to a wrong coronary territory. In this context, the implementation of the hybrid imaging approach, offering the chance to correctly reassign each segment to the pertinent coronary artery, can effectively overcome this limitation, therefore better guiding interventional procedures [23] . In fact, as elegantly shown by Herzog et al. [24] cardiac SPECT/MSCT hybrid imaging allows accurate prediction of ICA findings while minimizing radiation dose and imaging time, thus helping to avoid unnecessary invasive procedures.
Furthermore, the relevant prognostic value of hybrid cardiac SPECT/MSCT imaging has also been reported, and hybrid imaging has been shown to be highly accurate in the overall risk stratification of patients with known or suspected CAD [25] .
However, while hybrid imaging seems beneficial in terms of diagnostic accuracy and risk stratification, it obviously exposes the patient to a higher radiation dose. Indeed, because of the need to take into account the • Combined evaluation of myocardial viability and coronary anatomy to guide coronary revascularization possible long-term adverse consequences of ionizing radiations, the radiation burden must be continuously monitored and contained. The implementation of up-to-date MSCT acquisition protocols permits a radical reduction (60-80 %) of the radiation dose for an MSCT coronary angiography [8] . Similarly, omission of the rest acquisition when the stress study is normal may significantly reduce the total radiation burden of an MPI protocol without affecting the diagnostic accuracy [26] . Moreover, as hybrid imaging is becoming more widespread in clinical settings, its fields of application are becoming clear. It is generally accepted that, in a low-risk population of patients, cardiovascular imaging should primarily exclude the presence of significant coronary stenoses. In this setting, where MSCT angiography, due to its extremely elevated negative predictive value, might reasonably rule out the presence of CAD in the majority of patients, MPI could be performed only in the case of abnormal or equivocal results, limiting radiation burden and overall costs, as well as referrals for ICA [8] .
In a higher risk population, such as older patients with a higher probability of multivessel CAD and presumably more calcified coronary vessels, either SPECT or PET MPI should be considered as a first-line test, while MSCT angiography should be performed in the setting of equivocal MPI findings or in the case of suspected multivessel disease. In these patients, MSCT may be used to evaluate coronary wall anatomy and to quantify coronary artery calcium content, which is strongly associated with myocardial perfusion abnormalities and a validated predictor of adverse prognosis [8] .
Multimodality imaging: its role in non-atherosclerotic disease

Monitoring cardiotoxicity
Cardiotoxicity due to administration of cancer therapeutic agents such as anthracyclines is a well-characterized phenomenon [27] . While guidelines on the screening of chemotherapy-related cardiotoxicity (CRC) are still primarily based on serial assessment of left ventricular (LV) ejection fraction, recent advances in tissue characterization by cardiac MRI might allow early detection of high-risk patients prior to the development of LV dysfunction [28] . On the other hand, cardiac SPECT offers the chance to perform a combined evaluation of myocardial perfusion and function and may be ideal for the early diagnosis of CRC [27] .
Considering the strengths and weaknesses of each imaging modality, the future of screening will likely involve an algorithm which will include a multimodality approach to risk stratify patients prior to and shortly after starting chemotherapy, and to allow early diagnosis of initial signs of CRC. However, a comprehensive costeffectiveness evaluation of a multimodality imaging in CRC is warranted.
Amyloidosis
The diagnosis of cardiac amyloidosis remains challenging mainly because of the polymorphous clinical presentation. Cardiac MR offers key functional and morphological information on cardiac amyloidosis, providing a unique opportunity to perform non-invasive myocardial tissue characterization [29] . MR is particularly useful in patients with other causes of myocardial wall thickening, easily differentiating cardiac amyloidosis from other causes of myocardial hypertrophy. More recently, the role of nuclear techniques in the characterization of cardiac amyloidosis has been reported. A specific radiotracer, 99m Tc-diphosphonate, has been shown to localize cardiac amyloid deposits very sensitively, especially in patients with transthyretin-related disease. Indeed, asymptomatic cardiac transthyretin deposits can be identified through 99m Tc-diphosphonate scintigraphy at an early stage when serum cardiac biomarkers, and perhaps even MR, remain non-diagnostic [30] . By contrast, uptake of 99m Tc-diphosphonate occurs in about one-third of patients with cardiac light-chain amyloidosis, therefore 99m Tc-diphosphonate SPECT can help to distinguish these two types of disease [31] .
Advances in nuclear imaging and MSCT: high accuracy at lower radiation dose While cardiac SPECT has gained wide application in the clinical setting, its relatively low specificity and high radiation burden represent major drawbacks. Dedicated multipinhole cardiac cameras with CZT detectors have recently been introduced, demonstrating higher spatial resolution than standard SPECT cameras [14, 15] . In these cameras, the serial alignment of the CZT detectors makes it possible to cover the entire heart at the same time, abolishing the need for camera rotation around the patient. Moreover, the higher photon sensitivity of CZT cameras has allowed a significant reduction of injected dose, significantly reducing radiation burden while preserving diagnostic accuracy [16] .
A hybrid imaging approach has been applied to this novel nuclear technology by integrating a CZT camera with a highend 64-row MSCT. The implementation of this novel hybrid technology might allow better resource utilization and a contained radiation dose in patients with CAD [7] .
Likewise, the recent introduction of wide-area [64-row detector systems has represented a similar revolution in the MSCT field. In fact, thanks to dual-source and novel 320-row detector CT it is possible to obtain whole-heart imaging in one heartbeat, reducing artifacts while allowing a significant dose reduction [7] .
Furthermore, the high temporal resolution of these devices allows perfusion imaging of the entire heart at a single moment in time. This is due to greater contrast uniformity during the first pass of contrast, which theoretically enables a combined evaluation of coronary anatomy and myocardial perfusion. Initial validation of this integrated approach against standard SPECT showed a higher level of accuracy than MSCT coronary angiography alone [7] .
Hybrid PET/MRI imaging of the heart: present and future Hybrid PET/MR tomographs were only recently introduced onto the market due to the significant technical challenges inherent in the scanner design. In theory, hybrid PET/MR imaging has the potential to combine the MR-derived superior soft-tissue characterization (Fig. 4) with the extraordinary quality of PET-based functional imaging [21] . However, the additional value that this new modality might bring to the cardiac field has yet to be documented and its potential clinical role defined.
In fact, both MR and PET have independently gained wide acceptance for the assessment of myocardial perfusion and viability in different categories of patients [10, 32] . Thus, by combining the strengths of each modality, hybrid PET/MR imaging might ideally become the future ''gold standard'' for the evaluation of patients with LV systolic dysfunction, especially in the presence of CAD.
Although PET/MR imaging offers a clear reduction of radiation exposure, by eliminating CT-based tissue characterization, it might consistently increase workflow complexity and operational costs. Ultimately, the great strength of PET/MR will lie in its ability to deliver multimodal quantitative imaging parameters based on dynamic data acquisition with both modalities, offering a simultaneous physiological and biological quantitative characterization [33] .
While it is still not clear whether PET/MR will be able to offer added value or generate an additional demand for imaging studies that PET/CT cannot satisfy, we expect that the combination of molecular imaging with superb functional characterization of cardiac performance will contribute to better investigation of cardiac pathophysiology and to the development of predictive parameters for tissue recovery and response to therapy.
Conclusions
The use of multimodality imaging is becoming increasingly widespread in the evaluation of disparate cardiac conditions, allowing, through the 3-dimensional integration of complementary information derived from different imaging techniques, a rapid, non-invasive, anatomo-functional cardiac evaluation.
This approach has been associated with a higher diagnostic accuracy than that of standard single-modality assessment, while containing the overall radiation burden.
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